Roth Capital Issues Positive Estimate for MGRM Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM - Free Report) - Equities research analysts at Roth Capital increased their Q1 2025 earnings estimates for Monogram Orthopaedics in a research note issued on Thursday, March 13th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings per share of ($0.10) for the quarter, up from their previous estimate of ($0.11). The consensus estimate for Monogram Orthopaedics' current full-year earnings is ($0.49) per share. Roth Capital also issued estimates for Monogram Orthopaedics' Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.39) EPS, FY2025 earnings at ($0.70) EPS, Q1 2026 earnings at ($0.11) EPS, Q2 2026 earnings at ($0.11) EPS, Q3 2026 earnings at ($0.09) EPS, Q4 2026 earnings at ($0.30) EPS, FY2026 earnings at ($0.63) EPS and FY2027 earnings at ($0.24) EPS.

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.03.

Separately, Roth Mkm increased their price target on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the company a "buy" rating in a research report on Tuesday.

Remove Ads

Monogram Orthopaedics Trading Up 1.1 %

MGRM stock traded up $0.03 during midday trading on Monday, hitting $3.15. The company had a trading volume of 75,519 shares, compared to its average volume of 288,274. Monogram Orthopaedics has a 52 week low of $1.70 and a 52 week high of $4.90. The stock has a market cap of $111.27 million, a price-to-earnings ratio of -6.76 and a beta of 1.66. The stock's 50 day moving average price is $2.61 and its 200 day moving average price is $2.51.

Institutional Investors Weigh In On Monogram Orthopaedics

Large investors have recently made changes to their positions in the business. Jane Street Group LLC bought a new stake in Monogram Orthopaedics in the fourth quarter valued at $25,000. Northern Trust Corp increased its position in shares of Monogram Orthopaedics by 110.6% during the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company's stock valued at $109,000 after buying an additional 24,088 shares during the period. Wells Fargo & Company MN raised its stake in Monogram Orthopaedics by 286.6% in the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company's stock worth $27,000 after buying an additional 8,597 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Monogram Orthopaedics by 7.7% in the fourth quarter. Geode Capital Management LLC now owns 226,378 shares of the company's stock worth $537,000 after buying an additional 16,234 shares during the period. Finally, Orion Portfolio Solutions LLC purchased a new position in shares of Monogram Orthopaedics during the 4th quarter worth approximately $31,000. 0.45% of the stock is currently owned by institutional investors.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.